ストックスクリーナーアプリを入手
36.99
2.76%
-1.05
前日終値:
$38.04
開ける：
$37.99
24時間の取引高:
1.59M
Relative Volume:
0.79
時価総額：
$3.26B
収益：
$170.10M
当期純損益:
$-239.59M
株価収益率:
-13.21
EPS:
-2.8
ネットキャッシュフロー:
$-191.20M
1週間 パフォーマンス:
-10.26%
1か月 パフォーマンス:
-15.20%
6か月 パフォーマンス:
-21.83%
1年 パフォーマンス:
-45.73%
1日の値動き範囲:
$36.93
$38.20
1週間の範囲:
$36.93
$42.72
52週間の値動き範囲:
$36.52
$68.39
Crispr Therapeutics Ag Stock (CRSP) Company Profile
CRSP を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
CRSP
Crispr Therapeutics Ag
|
36.99 | 3.26B | 170.10M | -239.59M | -191.20M | -2.80 |
|
VRTX
Vertex Pharmaceuticals Inc
|
492.69 | 131.41B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
637.36 | 72.26B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
589.15 | 35.93B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
268.46 | 34.75B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beigene Ltd Adr
|
267.39 | 28.24B | 3.81B | -644.79M | -669.77M | -6.24 |
Crispr Therapeutics Ag Stock (CRSP) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-02-14 | アップグレード | Evercore ISI | In-line → Outperform |
| 2025-02-12 | アップグレード | TD Cowen | Sell → Hold |
| 2025-02-03 | 開始されました | H.C. Wainwright | Buy |
| 2024-08-06 | 繰り返されました | Needham | Buy |
| 2024-08-02 | 開始されました | Rodman & Renshaw | Buy |
| 2024-06-28 | 再開されました | Guggenheim | Neutral |
| 2024-02-15 | 開始されました | Wolfe Research | Peer Perform |
| 2023-12-11 | ダウングレード | TD Cowen | Market Perform → Underperform |
| 2023-10-17 | ダウングレード | Cantor Fitzgerald | Overweight → Neutral |
| 2023-09-27 | 開始されました | Mizuho | Buy |
| 2023-08-17 | アップグレード | Citigroup | Neutral → Buy |
| 2023-05-30 | 開始されました | William Blair | Outperform |
| 2023-04-13 | 開始されました | Cantor Fitzgerald | Overweight |
| 2023-03-21 | 開始されました | Bernstein | Mkt Perform |
| 2023-03-17 | 開始されました | Bryan Garnier | Buy |
| 2023-03-07 | 開始されました | Robert W. Baird | Neutral |
| 2022-10-11 | 開始されました | Morgan Stanley | Underweight |
| 2022-08-09 | ダウングレード | Barclays | Overweight → Equal Weight |
| 2022-06-23 | ダウングレード | Evercore ISI | Outperform → In-line |
| 2022-06-17 | 開始されました | BMO Capital Markets | Outperform |
| 2022-04-28 | 開始されました | Credit Suisse | Neutral |
| 2021-12-07 | 開始されました | Cowen | Market Perform |
| 2021-10-19 | 開始されました | SVB Leerink | Outperform |
| 2021-06-14 | アップグレード | Citigroup | Sell → Neutral |
| 2021-04-21 | アップグレード | Jefferies | Hold → Buy |
| 2021-03-04 | 開始されました | JMP Securities | Mkt Outperform |
| 2020-12-10 | 繰り返されました | Chardan Capital Markets | Buy |
| 2020-12-10 | ダウングレード | Jefferies | Buy → Hold |
| 2020-12-10 | 繰り返されました | Needham | Buy |
| 2020-12-07 | ダウングレード | Wells Fargo | Overweight → Equal Weight |
| 2020-10-23 | 開始されました | RBC Capital Mkts | Sector Perform |
| 2020-10-05 | 開始されました | BofA Securities | Buy |
| 2020-07-28 | 繰り返されました | Needham | Buy |
| 2020-07-14 | 開始されました | SunTrust | Buy |
| 2020-06-15 | 繰り返されました | Canaccord Genuity | Buy |
| 2020-03-05 | 開始されました | Stifel | Hold |
| 2020-02-03 | ダウングレード | Evercore ISI | Outperform → In-line |
| 2019-11-19 | アップグレード | William Blair | Mkt Perform → Outperform |
| 2019-11-12 | アップグレード | Oppenheimer | Perform → Outperform |
| 2019-08-01 | 開始されました | Jefferies | Buy |
| 2019-07-26 | 開始されました | Canaccord Genuity | Buy |
| 2019-06-10 | 開始されました | ROTH Capital | Buy |
| 2019-04-12 | 開始されました | Evercore ISI | Outperform |
| 2019-03-14 | 開始されました | William Blair | Mkt Perform |
| 2019-01-28 | ダウングレード | Goldman | Buy → Neutral |
| 2019-01-22 | ダウングレード | Citigroup | Neutral → Sell |
すべてを表示
Crispr Therapeutics Ag (CRSP) 最新ニュース
IQ EQ FUND MANAGEMENT IRELAND Ltd Has $1.43 Million Stake in CRISPR Therapeutics AG (NASDAQ:CRSP) - MarketBeat
Loomis Sayles & Co. L P Lowers Holdings in CRISPR Therapeutics AG (NASDAQ:CRSP) - MarketBeat
Promising Genomics & Synthetic Biology Stocks to Consider in 2025 - Yahoo Finance
Raymond James Financial Inc. Invests $3.23 Million in CRISPR Therapeutics AG (NASDAQ:CRSP) - MarketBeat
CRISPR Therapeutics (NasdaqGM:CRSP) COO Departure Announced Following 7% Share Price Decline - Yahoo Finance
CRISPR Therapeutics COO to step down in April By Investing.com - Investing.com South Africa
CRISPR Therapeutics COO to Step Down - Marketscreener.com
CRISPR Therapeutics COO Julianne Bruno Resigns - TipRanks
CRISPR Therapeutics COO to step down in April - Investing.com
CRISPR Therapeutics Announces Transition of Chief Operating Officer - GlobeNewswire
This CRISPR Therapeutics Insider Increased Their Holding In The Last Year - Yahoo Finance
Crispr therapeutics’ general counsel sells shares worth $131,317 By Investing.com - Investing.com Australia
Avantax Advisory Services Inc. Acquires Shares of 6,836 CRISPR Therapeutics AG (NASDAQ:CRSP) - MarketBeat
HighTower Advisors LLC Has $1.25 Million Stock Position in CRISPR Therapeutics AG (NASDAQ:CRSP) - MarketBeat
Is CRISPR Therapeutics AG (CRSP) a Promising Biotech Stock According to Wall Street Analysts - Insider Monkey
CRISPR Therapeutics Set To Reach Previous Heights (NASDAQ:CRSP) - Seeking Alpha
CRISPR Therapeutics AG (CRSP) Is a Trending Stock: Facts to Know Before Betting on It - MSN
Buy Rating for Crispr Therapeutics AG Driven by Promising Clinical Data and Diversified Pipeline - TipRanks
12 Most Promising Biotech Stocks According to Wall Street Analysts - Insider Monkey
Crispr therapeutics CFO Prasad Raju sells $90,582 in shares By Investing.com - Investing.com Australia
Crispr therapeutics CEO sells shares worth $413,578 By Investing.com - Investing.com South Africa
Crispr therapeutics COO Bruno Julianne sells $70,668 in stock By Investing.com - Investing.com Australia
Crispr therapeutics’ general counsel sells shares worth $131,317 - Investing.com India
Crispr therapeutics CFO Prasad Raju sells $90,582 in shares - Investing.com India
Crispr therapeutics COO Bruno Julianne sells $70,668 in stock - Investing.com
Crispr therapeutics CEO sells shares worth $413,578 - Investing.com
CRISPR Therapeutics AG (CRSP) Declines More Than Market: Some Information for Investors - MSN
Magnetar Financial LLC Buys New Stake in CRISPR Therapeutics AG (NASDAQ:CRSP) - MarketBeat
Koss Olinger Consulting LLC Has $1.35 Million Holdings in CRISPR Therapeutics AG (NASDAQ:CRSP) - MarketBeat
Contrarius Group Holdings Ltd Purchases Shares of 368,811 CRISPR Therapeutics AG (NASDAQ:CRSP) - MarketBeat
2 Beaten-Down Stocks to Buy on the Dip - Yahoo Finance
CRISPR Therapeutics AG (CRSP) Surpasses Market Returns: Some Facts Worth Knowing - MSN
Nikko Asset Management Americas Inc. Has $108.07 Million Position in CRISPR Therapeutics AG (NASDAQ:CRSP) - MarketBeat
CRISPR Therapeutics (NASDAQ:CRSP) Raised to Sell at StockNews.com - MarketBeat
CRISPR Therapeutics AG (NASDAQ:CRSP) Given Average Rating of "Hold" by Brokerages - MarketBeat
2 No-Brainer Biotech Stocks to Buy Right Now - Yahoo Finance
Is CRISPR Therapeutics (CRSP) One of the Most Shorted Stocks in 2025? - MSN
CRISPR Therapeutics Stock Trades Near 52-Week Low: Time to Buy or Sell? - Yahoo Finance
CRISPR Therapeutics AG (CRSP): A Bull Case Theory - Yahoo Finance
CRISPR Therapeutics (NASDAQ:CRSP) Trading 2.8% HigherHere's What Happened - MarketBeat
Crispr therapeutics CFO Prasad Raju sells $157,251 in shares By Investing.com - Investing.com South Africa
Crispr therapeutics CFO Prasad Raju sells $157,251 in shares - Investing.com
CRISPR Therapeutics CFO Sells Shares to Cover Tax Obligation - TradingView
CRISPR Therapeutics (CRSP): Among Top Stocks to Buy from Ark Invest’s Portfolio - Insider Monkey
Crispr Therapeutics Ag (CRSP) 財務データ
収益
当期純利益
現金流量
EPS
0.39%
0.34%
大文字化:
|
ボリューム (24 時間):